Literature DB >> 11548974

Clinical trials referral resource: Current clinical trials of the anti-VEGF monoclonal antibody bevacizumab.

H X Chen1, R E Gore-Langton, B D Cheson.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11548974

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN： 0890-9091            Impact factor:   2.990


× No keyword cloud information.
  10 in total

Review 1.  Dermatologic adverse events to targeted therapies in lower GI cancers: clinical presentation and management.

Authors:  Viswanath Reddy Belum; Andrea Cercek; Virginia Sanz-Motilva; Mario E Lacouture
Journal:  Curr Treat Options Oncol       Date:  2013-09

Review 2.  Inhibition of vascular endothelial growth factor in the treatment of solid tumors.

Authors:  Kim Margolin
Journal:  Curr Oncol Rep       Date:  2002-01       Impact factor: 5.075

3.  Microtubule-associated protein 4 is an important regulator of cell invasion/migration and a potential therapeutic target in esophageal squamous cell carcinoma.

Authors:  Y-Y Jiang; L Shang; Z-Z Shi; T-T Zhang; S Ma; C-C Lu; Y Zhang; J-J Hao; C Shi; F Shi; X Xu; Y Cai; X-M Jia; Q-M Zhan; M-R Wang
Journal:  Oncogene       Date:  2016-02-15       Impact factor: 9.867

4.  Inhibitors of Glioma Growth that Reveal the Tumour to the Immune System.

Authors:  Manuel Nieto-Sampedro; Beatriz Valle-Argos; Diego Gómez-Nicola; Alfonso Fernández-Mayoralas; Manuel Nieto-Díaz
Journal:  Clin Med Insights Oncol       Date:  2011-09-21

Review 5.  Animal models of diabetic retinopathy.

Authors:  Jose Quiroz; Amirfarbod Yazdanyar
Journal:  Ann Transl Med       Date:  2021-08

Review 6.  Biological response modifiers in cancer.

Authors:  Purabi Reang; Madhur Gupta; Kamlesh Kohli
Journal:  MedGenMed       Date:  2006-11-14

Review 7.  Phage display-derived human antibodies in clinical development and therapy.

Authors:  André Frenzel; Thomas Schirrmann; Michael Hust
Journal:  MAbs       Date:  2016-07-14       Impact factor: 5.857

8.  Potential Influence of Endothelial Adsorption on the Delayed Time to Maximum Concentration of Biopharmaceuticals.

Authors:  Joannes A A Reijers; Martijn J C Dane; Anton Jan van Zonneveld; Jacobus Burggraaf; Matthijs Moerland
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2018-02       Impact factor: 2.441

9.  The human cell surfaceome of breast tumors.

Authors:  Júlia Pinheiro Chagas da Cunha; Pedro Alexandre Favoretto Galante; Jorge Estefano Santana de Souza; Martin Pieprzyk; Dirce Maria Carraro; Lloyd J Old; Anamaria Aranha Camargo; Sandro José de Souza
Journal:  Biomed Res Int       Date:  2013-09-09       Impact factor: 3.411

Review 10.  Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium.

Authors:  Luca Falzone; Salvatore Salomone; Massimo Libra
Journal:  Front Pharmacol       Date:  2018-11-13       Impact factor: 5.810
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.